AI assistant
Sending…
AIM ImmunoTech Inc. — Director's Dealing 2011
Mar 3, 2011
35334_dirs_2011-03-03_d6677f12-35cc-4f4d-932b-3b4d6eb244f2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HEMISPHERX BIOPHARMA INC (HEB)
CIK: 0000946644
Period of Report: 2011-03-01
Reporting Person: Lander Russel J (VP of Process/QualityAssurance)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-03-01 | Common Stock | P | 25000 | $0.46 | Acquired | 182983 | Direct |
| 2011-03-01 | Common Stock | P | 25000 | $0.4595 | Acquired | 207983 | Direct |
More from AIM ImmunoTech Inc.
Governance Information
2026
Jun 10
Capital/Financing Update
2026
Jun 10
Capital/Financing Update
2026
Jun 8
Report Publication Announcement
2026
Jun 4
Capital/Financing Update
2026
May 21
Capital/Financing Update
2026
May 21
Share Issue/Capital Change
2026
May 19
Capital/Financing Update
2026
May 19
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 14